On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

House of Representatives

InstitutionResearch output, impact & collaborations

House of Representatives is a institution indexed in ScholarIQ from OpenAlex.

What is known about House of Representatives?

ScholarIQrecord summary

House of Representatives is a research organisation in The Hague, NL. OpenAlex records 4,845 works and 1,018,829 citations for it. 1,654 researchers list it as their most recent affiliation.

How many works does House of Representatives have?

ScholarIQindexed works

House of Representatives has 4,845 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does House of Representatives have?

ScholarIQcitation count

House of Representatives has 1,018,829 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at House of Representatives?

ScholarIQresearcher count

House of Representatives has 1,654 researchers in the ScholarIQ index.

What is the average h-index at House of Representatives?

ScholarIQavg h-index

House of Representatives has an average h-index of 65.5 in OpenAlex.

What is the ROR of House of Representatives?

ScholarIQror

The ROR for House of Representatives is on the source record.

What is the OpenAlex record for House of Representatives?

ScholarIQopenalex

The OpenAlex for House of Representatives is on the source record.

What is the Wikidata of House of Representatives?

ScholarIQwikidata

The Wikidata for House of Representatives is on the source record.

Who are the most-cited researchers behind House of Representatives?

ScholarIQtop researchers by citations
1
Maarten de Wit · Rheumatoid Arthritis Research and Therapies
298 works28,938 citations
2
Scott D. Halpern · Palliative Care and End-of-Life Issues
499 works18,002 citations

What are the most-cited papers on House of Representatives?

ScholarIQmost cited works
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update
Josef S Smolen, Robert Landewé, Johannes Bijlsma, Gerd Burmester, Katerina Chatzidionysiou, Maxime Dougados, J. Nam, Sofía Ramiro, Marieke Voshaar, Ronald van Vollenhoven, Daniel Aletaha, Martin Aringer, Maarten Boers, Christopher D. Buckley, Frank Buttgereit, Vivian P. Bykerk, Mario Cardiel, Bernard Combe, Maurizio Cutolo, Yvonne van Eijk‐Hustings, Paul Emery, Axel Finckh, Cem Gabay, Juan J. Gómez‐Reino, Laure Gossec, J.-E. Gottenberg, Johanna M W Hazes, T. Huizinga, Meghna Jani, Д. Е. Каратеев, Marios Kouloumas, Tore Kvien, Zhanguo Li, Xavier Mariette, Iain B. McInnes, Eduardo Mysler, Peter Nash, Karel Pavelká, Gyula Poór, Christophe Richez, Piet L. C. M. van Riel, Andrea Rubbert‐Roth, Kenneth G. Saag, José António Pereira da Silva, Tanja Stamm, Tsutomu Takeuchi, René Westhovens, Maarten de Wit, Désirée van der Heijde
Annals of the Rheumatic Diseases. 20175,784 CitationsOPEN ACCESS
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
Josef S Smolen, Robert Landewé, J. W. J. Bijlsma, Gerd R Burmester, Maxime Dougados, Andreas Kerschbaumer, Iain B. McInnes, Alexandre Sepriano, Ronald van Vollenhoven, Maarten de Wit, Daniel Aletaha, Martin Aringer, Johan Askling, Alejandro Balsa, Maarten Boers, Alfons A den Broeder, Maya H Buch, Frank Buttgereit, Roberto Caporali, Myrna Cardiel, Diederik De Cock, Cătălin Codreanu, Maurizio Cutolo, Christopher J Edwards, Yvonne van Eijk‐Hustings, Paul Emery, Axel Finckh, Laure Gossec, Jacques‐Eric Gottenberg, Merete Lund Hetland, T. Huizinga, Marios Koloumas, Zhanguo Li, Xavier Mariette, Ulf Müller‐Ladner, Eduardo Mysler, José António Pereira da Silva, Gyula Poór, Janet Pope, Andrea Rubbert‐Roth, Adeline Ruyssen‐Witrand, Kenneth G. Saag, Anja Strangfeld, Tsutomu Takeuchi, Marieke Voshaar, René Westhovens, Désirée van der Heijde
Annals of the Rheumatic Diseases. 20202,781 CitationsOPEN ACCESS
Treating rheumatoid arthritis to target: recommendations of an international task force
Josef S Smolen, D. Aletaha, J. W. J. Bijlsma, Ferdinand C Breedveld, Dimitrios T. Boumpas, G.-R. Burmester, Bernard Combe, M. Cutolo, Maarten de Wit, M Dougados, Paul Emery, Alan Gibofsky, Juan J. Gómez‐Reino, Boulos Haraoui, J. R. Kalden, Edward Keystone, T. K. Kvien, Iain B. McInnes, E. Martín‐Mola, Carlomaurizio Montecucco, M. Schoels, D. van der Heijde
Annals of the Rheumatic Diseases. 20102,102 CitationsOPEN ACCESS
American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials
David T. Felson, Josef S Smolen, George A. Wells, Bin Zhang, L. van Tuyl, Julia Funovits, Daniel Aletaha, Cornelia F Allaart, Joan M. Bathon, Stefano Bombardieri, Peter Brooks, Andrew Brown, Marco Matucci‐Cerinic, Hyon K. Choi, Bernard Combe, Maarten de Wit, Maxime Dougados, Paul Emery, Daniel E. Furst, Juan J. Gómez‐Reino, Gillian Hawker, Edward Keystone, Dinesh Khanna, John Kirwan, Tore K Kvien, Robert Landewé, Joachim Listing, Kaleb Michaud, E. Martín‐Mola, Pamela Montie, Theodore Pincus, Pamela Richards, Jeffrey N. Siegel, Lee S. Simon, Tuulikki Sokka, Vibeke Strand, Peter Tugwell, Alan Tyndall, Desirée van der Heijde, Suzanne Verstappen, Barbara White, Frederick Wolfe, A. Zink, Maarten Boers
Arthritis & Rheumatism. 20111,020 CitationsOPEN ACCESS
Shared decision making: really putting patients at the centre of healthcare
Anne M. Stiggelbout, Trudy van der Weijden, Maarten de Wit, Dominick L. Frosch, France Légaré, Víctor M. Montori, Lyndal Trevena, Glyn Elwyn
BMJ. 20121,012 CitationsOPEN ACCESS

How much of the research on House of Representatives is open access?

ScholarIQopen access share
80%OPEN ACCESS
Gold
0%
Green
10%
Hybrid
10%
Bronze
60%
Closed
20%

Related on ScholarIQ

470M+ articles · 14-day free trial